|
⚲
|
| Keyboard |
| Aulin Sherry
✚
|
|
|---|---|
| CIK # | 0001862144 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001862144] | |
| 4 | [0001862144] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Aulin Sherry | |
| Xenon Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2024-12-18 | Option exercise | 9,334 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2024-12-18 | Tax withheld | 2,135 | $41.28 | 88,133 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2024-12-18 | Tax withheld | 4,490 | $41.28 | 185,347 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2024-12-18 | Option exercise | 16,000 | $11.58 | 185,280 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2024-12-18 | Option exercise | 9,334 | $9.44 | 88,113 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2024-12-18 | Sell | 11,510 | $41.19 | 474,097 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2024-12-18 | Sell | 7,199 | $41.23 | 296,815 |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2024-12-18 | Option exercise | 16,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2024-03-11 | Grant | 100,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2023-03-10 | Grant | 120,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2022-09-02 | Option exercise | 813 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2022-09-02 | Option exercise | 2,292 | $3.10 | 7,105 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2022-09-02 | Option exercise | 6,511 | $4.75 | 30,927 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2022-09-02 | Tax withheld | 3,293 | $39.53 | 130,172 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2022-09-02 | Option exercise | 813 | $8.40 | 6,829 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2022-09-02 | Sell | 15,355 | $39.57 | 607,597 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2022-09-02 | Option exercise | 9,000 | $9.44 | 84,960 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2022-09-02 | Option exercise | 32 | $7.49 | 240 |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2022-09-02 | Option exercise | 6,511 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2022-09-02 | Option exercise | 2,292 | $0.00 | |
| showing 20 of 24 most recent transactions | |||||